Weight Gain After Fecal Microbiota Transplantation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Fecal microbiota transplantation (FMT) is a promising treatment for recurrent Clostridium difficile infection. We report a case of a woman successfully treated with FMT who developed new-onset obesity after receiving stool from a healthy but overweight donor. This case may stimulate further studies on the mechanisms of the nutritional-neural-microbiota axis and reports of outcomes in patients who have used nonideal donors for FMT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition to modulating immune responses, the composition of commensal microbiota has been linked to chronic diseases, with a theoretical risk of transferring obesity from donor to recipient (30).”
From The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies (2018) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“The hypothesis of FMT triggering or contributing to obesity is supported by animal models demonstrating that an obese microbiota can be transmitted [2].”
Youngster, I., Sauk, J., Pindar, C., Wilson, R. G., Kaplan, J. L., Smith, M. B., Alm, E. J., Gevers, D., Russell, G. H., & Hohmann, E. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu135 · Cited by 467 · cited 10×
“She improved and did not suffer a further CDI recurrence after FMT.”
BackgroundInfluentialReview article: associations between Helicobacter pylori and obesity - an ecological study
Lender, N., Talley, N. J., Enck, P., Haag, S., Zipfel, S., Morrison, M., & Holtmann, G. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12790 · Cited by 108
Cited by
Items 101–200 of 445
Approaches to studying and manipulating the enteric microbiome to improve autism symptoms
Frye, R. E., Slattery, J., MacFabe, D. F., Allen-Vercoe, E., Parker, W., Rodakis, J., Adams, J. B., Krajmalnik-Brown, R., Bolte, E., Kahler, S., et al. (2015) · Microbial Ecology in Health & Disease · doi:10.3402/mehd.v26.26878 · Cited by 73
Hudson, L. E., Anderson, S. E., Corbett, A. H., & Lamb, T. J. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00049-16 · Cited by 88
Fecal Microbiota Transplantation: The Evolving Risk Landscape
Gupta, S., Mullish, B. H., & Allegretti, J. R. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001075 · Cited by 84
The gut microbiome and efficacy of cancer immunotherapy
Roviello, G., Iannone, L. F., Bersanelli, M., Mini, E., & Catalano, M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107973 · Cited by 84
Cryopreservation of artificial gut microbiota produced with in vitro fermentation technology
Bircher, L., Schwab, C., Geirnaert, A., & Lacroix, C. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12844 · Cited by 83
Ganci, M., Suleyman, E., Butt, H., & Ball, M. (2019) · Brain and Behavior · doi:10.1002/brb3.1408 · Cited by 83
de Clercq, N. C., van den Ende, T., Prodan, A., Hemke, R., Davids, M., Pedersen, H., Nielsen, H. B., Groen, A. K., de Vos, W. M., van Laarhoven, H. W. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4918 · Cited by 84
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N., Iqbal, T. H., et al. (2018) · Journal of Hospital Infection · doi:10.1016/j.jhin.2018.07.037 · Cited by 79
McCormack, U. M. M., Curião, T., Wilkinson, T., Metzler-Zebeli, B. U., Reyer, H., Ryan, T., Díaz, J. A. C., Crispie, F., Cotter, P. D., Creevey, C. J., et al. (2018) · mSystems · doi:10.1128/msystems.00134-17 · Cited by 80
Ghimire, S., Roy, C., Wongkuna, S., Antony, L., Fenske, G. J., Maji, A., Keena, M. C., Foley, A., & Scaria, J. (2020) · mSystems · doi:10.1128/msystems.00620-19 · Cited by 79
Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice
Kulecka, M., Paziewska, A., Zeber-Lubecka, N., Ambrozkiewicz, F., Kopczynski, M., Kuklinska, U., Pysniak, K., Gajewska, M., Mikula, M., & Ostrowski, J. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0116-8 · Cited by 67
Dysbiosis in Functional Bowel Disorders
Enck, P., & Mazurak, N. (2018) · Annals of Nutrition and Metabolism · doi:10.1159/000488773 · Cited by 68
Sbahi, H., & Di Palma, J. A. (2016) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2016-000087 · Cited by 75
“Factors signi fi cantly associated with greater success of FMT include a recent diagnosis of UC ( ≤ 1 year) and being on immunosuppressants at the time of FMT.”
BackgroundInfluentialThe role of gut microbiota in Clostridium difficile infection
Samarkos, M., Mastrogianni, E., & Kampouropoulou, O. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.02.006 · Cited by 75
“There have been cases of faecal aspiration and interestingly, one case of obesity, which developed after FMT from a healthy but overweight donor [66,67].”
BackgroundStable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut
Hsu, B. B., Way, J. C., & Silver, P. A. (2020) · mSystems · doi:10.1128/msystems.00013-20 · Cited by 72
Amrane, S., Hocquart, M., Afouda, P., Kuete, E., Pham, T.-P.-T., Dione, N., Ngom, I. I., Valles, C., Bachar, D., Raoult, D., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49189-8 · Cited by 73
Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease
Vaughn, B. P., Rank, K. M., & Khoruts, A. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.026 · Cited by 70
DeLeon, O., Mocanu, M., Tan, A., Sidebottom, A. M., Koval, J., Ceccato, H. D., Kralicek, S. E., Colgan, J. J., George, M. M. S., Lake, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.014 · Cited by 74
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
Sunkara, T., Rawla, P., Ofosu, A., & Gaduputi, V. V. (2018) · Journal of Inflammation Research · doi:10.2147/jir.s176190 · Cited by 72
Potential in vivo delivery routes of postbiotics
Abbasi, A., Hajipour, N., Hasannezhad, P., Baghbanzadeh, A., & Maleki, L. A. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1865260 · Cited by 71
Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature
Cohen, N. A., & Maharshak, N. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4535-9 · Cited by 71
Lahtinen, P., Mattila, E. J., Anttila, V., Tillonen, J., Teittinen, M., Nevalainen, P. I., Salminen, S., Satokari, R. M., & Arkkila, P. E. T. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i39.7174 · Cited by 69
Polyphenols, the new frontiers of prebiotics
Nazzaro, F., Fratianni, F., Feo, V. D., Battistelli, A., da Cruz, A. G., & Coppola, R. (2020) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2020.06.002 · Cited by 70
Fecal microbiota transplantation: Uses, questions, and ethics
Grigoryan, Z., Shen, M. J., Twardus, S. W., Beuttler, M. M., Chen, L. A., & Bateman-House, A. (2020) · Medicine in Microecology · doi:10.1016/j.medmic.2020.100027 · Cited by 69
Horne, R. G., Yu, Y., Zhang, R., Abdalqadir, N., Rossi, L., Surette, M. G., Sherman, P. M., & Adeli, K. (2020) · Nutrients · doi:10.3390/nu12113557 · Cited by 69
Almanza‐Aguilera, E., Cano, A., Gil‐Lespinard, M., Burguera, N., Zamora‐Ros, R., Agudo, A., & Farràs, M. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.08.001 · Cited by 67
Microbiota Replacement Therapies: Innovation in Gastrointestinal Care
Khanna, S. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.923 · Cited by 62
Host-microbial interactions in the metabolism of different dietary fats
Chadaideh, K. S., & Carmody, R. N. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.04.011 · Cited by 67
Using bioreactors to study the effects of drugs on the human microbiota
Guzmán-Rodríguez, M., McDonald, J. A. K., Hyde, R., Allen‐Vercoe, E., Claud, E. C., Sheth, P. M., & Petrof, E. O. (2018) · Methods · doi:10.1016/j.ymeth.2018.08.003 · Cited by 65
A Gut Odyssey: The Impact of the Microbiota on Clostridium difficile Spore Formation and Germination
Shen, A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005157 · Cited by 64
Riley, L. W., & Blanton, R. E. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.ame-0001-2018 · Cited by 63
Commentary on key aspects of fecal microbiota transplantation in small animal practice
García-Mazcorro, J. F., Chaitman, J., Jergens, A., Gaschen, F. P., Marks, S. L., Marroquín-Cardona, A. G., Richter, K. P., Rossi, G., Suchodolski, J. S., & Weese, J. S. (2016) · Veterinary Medicine Research and Reports · doi:10.2147/vmrr.s105238 · Cited by 62
Kazemian, N., Ramezankhani, M., Sehgal, A., Khalid, F. M., Kalkhoran, A. H. Z., Narayan, A., Wong, G. K.-S., Kao, D., & Pakpour, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-75162-x · Cited by 61
Singh, S., Kriti, M., Anamika, K. S., Sarma, D. K., Verma, V., Nagpal, R., Mohania, D., Tiwari, R. R., & Kumar, M. (2024) · Metabolism Open · doi:10.1016/j.metop.2024.100287 · Cited by 61
Tariq, R., Weatherly, R. M., Kammer, P. P., Pardi, D. S., & Khanna, S. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000768 · Cited by 61
Fecal microbiota transplantation in non-communicable diseases: Recent advances and protocols
Hamamah, S., Gheorghita, R. E., Lobiuc, A., Sîrbu, I. O., & Covașă, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1060581 · Cited by 60
Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation
Gulati, A., Nicholson, M. R., Khoruts, A., & Kahn, S. A. (2022) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002167 · Cited by 59
Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese Cats
Ma, X., Brinker, E. J., Graff, E. C., Cao, W., Gross, A. L., Johnson, A. K., Zhang, C., Martin, D. R., & Wang, X. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00837-22 · Cited by 58
2020 vision – An overview of prospects for diabetes management and prevention in the next decade
Wang, C., Neil, D. L., & Home, P. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.06.007 · Cited by 57
Fecal microbiota transplantation in children: a brief review
Hourigan, S. K., & Oliva‐Hemker, M. M. (2016) · Pediatric Research · doi:10.1038/pr.2016.48 · Cited by 56
Isolauri, E. (2017) · Nestlé Nutrition Institute Workshop series · doi:10.1159/000455217 · Cited by 56
Stripling, J., & Rodriguez, M. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.08.010 · Cited by 48
Role of the microbiome in oral cancer occurrence, progression and therapy
Li, Z., Liu, Y., & Zhang, L. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105638 · Cited by 56
Kelly, B. J., & Tebas, P. (2017) · CHEST Journal · doi:10.1016/j.chest.2017.09.002 · Cited by 54
Devaux, C. A., & Raoult, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01379 · Cited by 54
Regulation of Microbiota by Vitamin D Receptor: A Nuclear Weapon in Metabolic Diseases
Bakke, D., Chatterjee, I., Agrawal, A., Dai, Y. D., & Sun, J. (2018) · Nuclear Receptor Research · doi:10.11131/2018/101377 · Cited by 51
The Role of the Human Microbiome in Chemical Toxicity
Koontz, J. M., Dancy, B. C. R., Horton, C. L., Stallings, J. D., DiVito, V. T., & Lewis, J. A. (2019) · International Journal of Toxicology · doi:10.1177/1091581819849833 · Cited by 51
Improving Risk–Benefit in Faecal Transplantation through Microbiome Screening
Papanicolas, L. E., Gordon, D., Wesselingh, S. L., & Rogers, G. B. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2019.12.009 · Cited by 49
Tian, S., Kim, M. S., Zhao, J., Heber, K., Hao, F., Koslicki, D., Tian, S., Singh, V., Patterson, A. D., & Bisanz, J. E. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.02.007 · Cited by 49
Fluitman, K. S., de Clercq, N. C., Keijser, B. J. F., Visser, M., Nieuwdorp, M., & IJzerman, R. G. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1318060 · Cited by 50
Zhang, K., Zhang, Q., Qiu, H., Ma, Y., Hou, N., Zhang, J., Kan, C., Han, F., Sun, X., & Shi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37609 · Cited by 48
Broecker, F., Klumpp, J., & Moelling, K. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13100 · Cited by 48
Recruitment of feces donors among blood donors: Results from an observational cohort study
Baunwall, S. M. D., Erikstrup, C., Dinh, K. M., Lemming, L. E., Dahlerup, J. F., & Hvas, C. L. (2018) · Gut Microbes · doi:10.1080/19490976.2018.1458179 · Cited by 48
Ojima, M. N., Gotoh, A., Takada, H., Odamaki, T., Xiao, J., Katoh, T., & Katayama, T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01349 · Cited by 48
How gut microbes are joining the fight against cancer
Guglielmi, G. (2018) · Nature · doi:10.1038/d41586-018-05208-8 · Cited by 47
Adverse events of fecal microbiota transplantation: a metaanalysis of high-quality studies
Michailidis, L., Currier, A. C., Le, M., & Flomenhoft, D. R. (2021) · Annals of Gastroenterology · doi:10.20524/aog.2021.0655 · Cited by 48
Microbiota and epigenetics: promising therapeutic approaches?
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-15623-6 · Cited by 47
Spinler, J. K., Ross, C. L., & Savidge, T. (2016) · Anaerobe · doi:10.1016/j.anaerobe.2016.05.007 · Cited by 46
Delaune, V., Orci, L. A., Lacotte, S., Peloso, A., Schrenzel, J., Lazarević, V., & Toso, C. (2018) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1518424 · Cited by 46
Hourigan, S. K., Ahn, M., Gibson, K. M., Pérez-Losada, M., Felix, G., Weidner, M., Leibowitz, I., Niederhuber, J. E., Sears, C. L., Crandall, K. A., et al. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofz379 · Cited by 43
A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression
Iruzubieta, P., Medina, J. M., Fernández-López, R., Crespo, J., & de la Cruz, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051369 · Cited by 47
Wong, G. C., Montgomery, J. M., & Taylor, M. W. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.autismspectrumdisorders.2021 · Cited by 47
Turning Participatory Microbiome Research into Usable Data: Lessons from the American Gut Project
Debelius, J. W., Vázquez‐Baeza, Y., McDonald, D. T., Xu, Z. Z., Wolfe, E., & Knight, R. D. (2016) · Journal of Microbiology and Biology Education · doi:10.1128/jmbe.v17i1.1034 · Cited by 45
Microbiota e barreira intestinal: implicações para obesidade
Oliveira, A. M., & Hammes, T. O. (2016) · Clinical & Biomedical Research · doi:10.4322/2357-9730.67683 · Cited by 47
Evolutionary and ecological forces that shape the bacterial communities of the human gut
Messer, J. S., Liechty, E. R., Vogel, O. A., & Chang, E. B. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.138 · Cited by 46
Ma, Y., Yang, J., Cui, B., Xu, H., Xiao, C., & Zhang, F. (2017) · BMC Medical Ethics · doi:10.1186/s12910-017-0200-2 · Cited by 44
Control of Clostridium difficile Infection by Defined Microbial Communities
Collins, J., & Auchtung, J. M. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0009-2016 · Cited by 44
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Koopen, A. M., Groen, A. K., & Nieuwdorp, M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000357 · Cited by 40
Relationship between Diet, Microbiota, and Healthy Aging
Sanchez-Morate, E., Gimeno-Mallench, L., Stromsnes, K., Sanz‐Ros, J., Román-Domínguez, A., Parejo-Pedrajas, S., Inglés, M., González, G. O., Gambini, J., & Mas‐Bargues, C. (2020) · Biomedicines · doi:10.3390/biomedicines8080287 · Cited by 43
Fecal Microbiota Transplantation during and Post-COVID-19 Pandemic
Kazemian, N., Kao, D. H., & Pakpour, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063004 · Cited by 43
Current and future applications of fecal microbiota transplantation for children
Chen, C.-C., & Chiu, C. (2021) · Biomedical Journal · doi:10.1016/j.bj.2021.11.004 · Cited by 43
Daillère, R., Derosa, L., Bonvalet, M., Segata, N., Routy, B., Gariboldi, M., Budinská, E., De Vries, I. J. M., Naccarati, A. G., Zitvogel, V., et al. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1774298 · Cited by 38
Pession, A., Zama, D., Muratore, E., Leardini, D., Gori, D., Guaraldi, F., Prete, A., Turroni, S., Brigidi, P., & Masetti, R. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020100 · Cited by 42
Probiotic lactic acid bacteria – the fledgling cuckoos of the gut?
Berstad, A., Raa, J., Midtvedt, T., & Valeur, J. (2016) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v27.31557 · Cited by 41
Hartstra, A. V., Nieuwdorp, M., & Herrema, H. (2016) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2016.08.009 · Cited by 41
The remedy within: will the microbiome fulfill its therapeutic promise?
Thaiss, C. A., & Elinav, E. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1563-z · Cited by 42
The intestinal microbiota as a therapeutic target in the treatment of NAFLD and ALD
Huang, W., & Kong, D. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111235 · Cited by 41
Genome Editing of Food-Grade Lactobacilli To Develop Therapeutic Probiotics
van Pijkeren, J.-P., & Barrangou, R. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.bad-0013-2016 · Cited by 37
Strategies to increase the efficacy of using gut microbiota for the modulation of obesity
Li, J., Rajoka, M. S. R., Shao, D., Jiang, C., Jin, M., Huang, Q., Yang, H., & Shi, J. (2017) · Obesity Reviews · doi:10.1111/obr.12590 · Cited by 40
Back to the future in a petri dish: Origin and impact of resurrected microbes in natural populations
Houwenhuyse, S., Macke, E., Reyserhove, L., Bulteel, L., & Decaestecker, E. (2017) · Evolutionary Applications · doi:10.1111/eva.12538 · Cited by 41
Targeting the Gut Microbiota to Treat Cachexia
Genton, L., Mareschal, J., Charretier, Y., Lazarević, V., Bindels, L. B., & Schrenzel, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00305 · Cited by 40
Discovery of a bacterial peptide as a modulator of GLP-1 and metabolic disease
Tomaro-Duchesneau, C., LeValley, S. L., Roeth, D., Sun, L. T., Horrigan, F. T., Kalkum, M., Hyser, J. M., & Britton, R. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-61112-0 · Cited by 40
Hirano, R., Sakanaka, M., Yoshimi, K., Sugimoto, N., Eguchi, S., Yamauchi, Y., Nara, M., Maeda, S., Ami, Y., Gotoh, A., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1973835 · Cited by 43
Gastroenterologist perceptions of faecal microbiota transplantation
Paramsothy, S., Walsh, A. J., Borody, T., Samuel, D., van den Bogaerde, J., Leong, R. W., Connor, S., Ng, W., Mitchell, H. M., Kaakoush, N. O., et al. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i38.10907 · Cited by 40
Gonzales-Luna, A. J., Carlson, T. J., & Garey, K. W. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad642 · Cited by 39
Shen, Z., Zhu, C., Quan, Y., Yuan, W., Wu, S., Yang, Z., Luo, W., Tan, B., & Wang, X. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13861 · Cited by 39
Microbes: possible link between modern lifestyle transition and the rise of metabolic syndrome
Moossavi, S., & Bishehsari, F. (2018) · Obesity Reviews · doi:10.1111/obr.12784 · Cited by 39
Wang, J., Kim, B. S., Han, K., & Kim, H. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14060555 · Cited by 38
Recent Progress in Metabolic Syndrome Research and Therapeutics
Kao, T., & Huang, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136862 · Cited by 38
Nigam, M., Panwar, A. S., & SINGH, R. K. (2022) · Frontiers in Medical Technology · doi:10.3389/fmedt.2022.961569 · Cited by 38
Wortelboer, K., Koopen, A. M., Herrema, H., de Vos, W. M., Nieuwdorp, M., & Kemper, E. M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1077275 · Cited by 38
Research Progress of Fecal Microbiota Transplantation in Liver Diseases
Zhao, Y., Chen, G., Xu, J., Chen, D., Yang, B., Chen, Z., & Wei, L. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041683 · Cited by 38
The link among microbiota, epigenetics, and disease development
El-Sayed, A., Aleya, L., & Kamel, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-13862-1 · Cited by 38
Losing weight for a better health: Role for the gut microbiota
Dao, M. C., Everard, A., Clément, K., & Cani, P. D. (2015) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2015.12.001 · Cited by 37
Zhuang, Y.-P., Zhou, H., Chen, H., Zheng, M.-Y., Liang, Y., Gu, Y.-T., Li, W., Qiu, W., & Zhou, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115040 · Cited by 37
Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
Wang, A. Y., Popov, J., & Pai, N. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i47.10304 · Cited by 38
Zoll, J., Read, M. N., Heywood, S. E., Estevez, E., Marshall, J. P. S., Kammoun, H. L., Allen, T. L., Holmes, A. J., Febbraio, M. A., & Henstridge, D. C. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00037.2020 · Cited by 35
Combatting Antibiotic Resistance: Leveraging Fecal Microbial Transplantation for Gut Health
Upreti, P., Devhare, L., Abdulmageed, L. H., Kumar, Y. G., Kumar, R., & Dharmamoorthy, G. (2024) · Springer eBooks · doi:10.1007/978-981-97-5272-0_10 · Cited by 35
Leong, K. S. W., Jayasinghe, T. N., Derraik, J. G. B., Albert, B. B., Chiavaroli, V., Svirskis, D. M., Beck, K. L., Conlon, C. A., Jiang, Y., Schierding, W. S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026174 · Cited by 35
An Overview of Gut Microbiota and Colon Diseases with a Focus on Adenomatous Colon Polyps
Pop, O. L., Vodnar, D. C., Diaconeasa, Z. M., Istrati, M., Bințințan, A., Bintintan, V. V., Suharoschi, R., & Gabbianelli, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197359 · Cited by 37
Metadata
- Authors
- Alang, N., & Kelly, C. R.
- Affiliations
- Newport Hospital (US)
- Brown University (US)
- Corresponding author
- Alang, Neha
- ORCID
- Kelly, Colleen R.
- Venue
- Open Forum Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-01-01
- Volume
- 2
- Issue
- 1
- Pages
- ofv004-ofv004
- ISSN
- 2328-8957 (ISSN-L)
- PMC
- PMC4438885
- OpenAlex
- W2121441667
- Cited by
- 403
- References
- 3
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 16 · 2023: 25 · 2022: 33 · 2021: 33 · 2020: 46 · 2019: 40 · 2018: 52 · 2017: 52 · 2016: 57 · 2015: 27
- FWCI
- 48.80
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Open Forum Infectious Diseases (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- fecal microbiota transplantation, weight gain, donor obesity, Clostridium difficile infection, recurrent infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.